{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:05:37Z","timestamp":1764698737585,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81560342"],"award-info":[{"award-number":["81560342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11239-018-1689-z","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T05:24:02Z","timestamp":1528176242000},"page":"409-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Abnormal fibrinogen with an A\u03b1 16Arg\u2009\u2192\u2009Cys substitution is associated with multiple cerebral infarctions"],"prefix":"10.1007","volume":"46","author":[{"given":"Meiling","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiqiu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"8","key":"1689_CR1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","volume":"3","author":"MW Mosesson","year":"2005","unstructured":"Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3(8):1894\u20131904. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01365.x","journal-title":"J Thromb Haemost"},{"issue":"5","key":"1689_CR2","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","volume":"109","author":"GA Tennent","year":"2007","unstructured":"Tennent GA, Brennan SO, Stangou AJ, O\u2019Grady J, Hawkins PN, Pepys MB (2007) Human plasma fibrinogen is synthesized in the liver. Blood 109(5):1971\u20131974. https:\/\/doi.org\/10.1182\/blood-2006-08-040956","journal-title":"Blood"},{"key":"1689_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cca.2015.06.002","volume":"447","author":"J Yan","year":"2015","unstructured":"Yan J, Deng D, Luo M, Cheng P, Chi B, Yuan Y, Liao L, Lin F (2015) Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature. Clin Chim Acta 447:86\u201389. https:\/\/doi.org\/10.1016\/j.cca.2015.06.002","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1689_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/s-0036-1571340","volume":"42","author":"M Neerman-Arbez","year":"2016","unstructured":"Neerman-Arbez M, de Moerloose P, Casini A (2016) Laboratory and genetic investigation of mutations accounting for congenital fibrinogen disorders. Semin Thromb Hemost 42(4):356\u2013365. https:\/\/doi.org\/10.1055\/s-0036-1571340","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"1689_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1055\/s-0037-1613368","volume":"89","author":"L Medved","year":"2003","unstructured":"Medved L, Nieuwenhuizen W (2003) Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost 89(3):409\u2013419","journal-title":"Thromb Haemost"},{"issue":"3","key":"1689_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/ATVBAHA.110.213389","volume":"31","author":"ST Lord","year":"2011","unstructured":"Lord ST (2011) Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol 31(3):494\u2013499. https:\/\/doi.org\/10.1161\/ATVBAHA.110.213389","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1689_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2007-994933","volume":"25","author":"MW Mosesson","year":"1999","unstructured":"Mosesson MW (1999) Dysfibrinogenemia and thrombosis. Semin Thromb Hemost 25(3):311\u2013319. https:\/\/doi.org\/10.1055\/s-2007-994933","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"1689_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2141.2006.06129.x","volume":"134","author":"VH Flood","year":"2006","unstructured":"Flood VH, Al-Mondhiry HA, Farrell DH (2006) The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance. Br J Haematol 134(2):220\u2013226. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06129.x","journal-title":"Br J Haematol"},{"issue":"11","key":"1689_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1043\/0003-9985(2002)126<1387:DAT>2.0.CO;2","volume":"126","author":"T Hayes","year":"2002","unstructured":"Hayes T (2002) Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 126(11):1387\u20131390. https:\/\/doi.org\/10.1043\/0003-9985(2002)126%3C1387:DAT%3E2.0.CO;2","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1689_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jth.12916","volume":"13","author":"A Casini","year":"2015","unstructured":"Casini A, Neerman-Arbez M, Ariens RA, de Moerloose P (2015) Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost 13(6):909\u2013919. https:\/\/doi.org\/10.1111\/jth.12916","journal-title":"J Thromb Haemost"},{"issue":"3","key":"1689_CR11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.V96.3.1191","volume":"96","author":"T Tarumi","year":"2000","unstructured":"Tarumi T, Martincic D, Thomas A, Janco R, Hudson M, Baxter P, Gailani D (2000) Familial thrombophilia associated with fibrinogen paris V: Dusart syndrome. Blood 96(3):1191\u20131193","journal-title":"Blood"},{"issue":"1","key":"1689_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1172\/JCI114154","volume":"84","author":"DK Galanakis","year":"1989","unstructured":"Galanakis DK, Henschen A, Peerschke EI, Kehl M (1989) Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly. J Clin Investig 84(1):295\u2013304. https:\/\/doi.org\/10.1172\/JCI114154","journal-title":"J Clin Investig"},{"issue":"7","key":"1689_CR13","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1182\/blood.V78.7.1744.1744","volume":"78","author":"MH Lee","year":"1991","unstructured":"Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J (1991) Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization. Blood 78(7):1744\u20131752","journal-title":"Blood"},{"issue":"2","key":"1689_CR14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0038-1657746","volume":"54","author":"P Reber","year":"1985","unstructured":"Reber P, Furlan M, Beck EA, Finazzi G, Buelli M, Barbui T (1985) Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues. Thromb Haemost 54(2):390\u2013393","journal-title":"Thromb Haemost"},{"issue":"7","key":"1689_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/MBC.0b013e32833e4284","volume":"21","author":"R Kotlin","year":"2010","unstructured":"Kotlin R, Blazek B, Suttnar J, Maly M, Kvasnicka J, Dyr JE (2010) Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Blood Coagul Fibrinolysis 21(7):640\u2013648. https:\/\/doi.org\/10.1097\/MBC.0b013e32833e4284","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"1689_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1172\/JCI106673","volume":"50","author":"HR Gralnick","year":"1971","unstructured":"Gralnick HR, Givelber HM, Shainoff JR, Finlayson JS (1971) Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Investig 50(9):1819\u20131830. https:\/\/doi.org\/10.1172\/JCI106673","journal-title":"J Clin Investig"},{"issue":"5","key":"1689_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/MBC.0000000000000290","volume":"26","author":"Q Bin","year":"2015","unstructured":"Bin Q, Liang F, Ou DY, Cui HR, Luo JM (2015) Two symptomatic cases of dysfibrinogenemia in China: one with gamma-chain Arg275Cys mutation and another without detectable mutation in fibrinogen genes. Blood Coagul Fibrinolysis 26(5):564\u2013571. https:\/\/doi.org\/10.1097\/MBC.0000000000000290","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1689_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2157-1","author":"J Yan","year":"2016","unstructured":"Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F (2016) A novel mutation in the fibrinogen Aalpha chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release. Int J Hematol. https:\/\/doi.org\/10.1007\/s12185-016-2157-1","journal-title":"Int J Hematol"},{"issue":"39","key":"1689_CR19","doi-asserted-by":"publisher","first-page":"e4864","DOI":"10.1097\/MD.0000000000004864","volume":"95","author":"M Luo","year":"2016","unstructured":"Luo M, Deng D, Xiang L, Cheng P, Liao L, Deng X, Yan J, Lin F (2016) Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His. Medicine 95(39):e4864. https:\/\/doi.org\/10.1097\/MD.0000000000004864","journal-title":"Medicine"},{"issue":"1","key":"1689_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1055\/s-0037-1612912","volume":"85","author":"H Tanaka","year":"2001","unstructured":"Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N (2001) Fibrinogen Matsumoto V: a variant with Aalpha19 Arg\u2013>Gly (AGG\u2013>GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Thromb Haemost 85(1):108\u2013113","journal-title":"Thromb Haemost"},{"issue":"5","key":"1689_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.thromres.2005.10.016","volume":"118","author":"R Marchi","year":"2006","unstructured":"Marchi R, Carvajal Z, Meyer M, Soria J, Ruiz-Saez A, Arocha-Pinango CL, Weisel JW (2006) Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA). Thromb Res 118(5):637\u2013650. https:\/\/doi.org\/10.1016\/j.thromres.2005.10.016","journal-title":"Thromb Res"},{"issue":"4","key":"1689_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0036-1571339","volume":"42","author":"A Casini","year":"2016","unstructured":"Casini A, de Moerloose P, Neerman-Arbez M (2016) Clinical Features and management of congenital fibrinogen deficiencies. Semin Thromb Hemost 42(4):366\u2013374. https:\/\/doi.org\/10.1055\/s-0036-1571339","journal-title":"Semin Thromb Hemost"},{"key":"1689_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1749-6632.2001.tb03495.x","volume":"936","author":"M Hanss","year":"2001","unstructured":"Hanss M, Biot F (2001) A database for human fibrinogen variants. Ann N Y Acad Sci 936:89\u201390","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1689_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/blood-2014-06-582866","volume":"125","author":"A Casini","year":"2015","unstructured":"Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, Gautier P, Biron C, Neerman-Arbez M, de Moerloose P (2015) Natural history of patients with congenital dysfibrinogenemia. Blood 125(3):553\u2013561. https:\/\/doi.org\/10.1182\/blood-2014-06-582866","journal-title":"Blood"},{"issue":"1","key":"1689_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MBC.0b013e328331e6db","volume":"21","author":"W Miesbach","year":"2010","unstructured":"Miesbach W, Scharrer I, Henschen A, Neerman-Arbez M, Spitzer S, Galanakis D (2010) Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects. Blood Coagul Fibrinolysis 21(1):35\u201340. https:\/\/doi.org\/10.1097\/MBC.0b013e328331e6db","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"1689_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0038-1653741","volume":"73","author":"F Haverkate","year":"1995","unstructured":"Haverkate F, Samama M (1995) Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 73(1):151\u2013161","journal-title":"Thromb Haemost"},{"issue":"4","key":"1689_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bcmd.2015.06.002","volume":"55","author":"J Zhou","year":"2015","unstructured":"Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J, Lu Y, Wu X, Liang Q, Wang H, Wang X (2015) Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia. Blood Cells Mol Dis 55(4):308\u2013315. https:\/\/doi.org\/10.1016\/j.bcmd.2015.06.002","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"1689_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chroma.2005.04.059","volume":"1077","author":"S Garbis","year":"2005","unstructured":"Garbis S, Lubec G, Fountoulakis M (2005) Limitations of current proteomics technologies. J Chromatogr A 1077(1):1\u201318","journal-title":"J Chromatogr A"},{"key":"1689_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1749-6632.2001.tb03491.x","volume":"936","author":"MW Mosesson","year":"2001","unstructured":"Mosesson MW, Siebenlist KR, Meh DA (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936:11\u201330","journal-title":"Ann N Y Acad Sci"},{"issue":"21","key":"1689_CR30","doi-asserted-by":"publisher","first-page":"18875","DOI":"10.1074\/jbc.M110977200","volume":"277","author":"T Rose","year":"2002","unstructured":"Rose T, Di Cera E (2002) Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem 277(21):18875\u201318880. https:\/\/doi.org\/10.1074\/jbc.M110977200","journal-title":"J Biol Chem"},{"issue":"10","key":"1689_CR31","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2012-09-306639","volume":"121","author":"JW Weisel","year":"2013","unstructured":"Weisel JW, Litvinov RI (2013) Mechanisms of fibrin polymerization and clinical implications. Blood 121(10):1712\u20131719. https:\/\/doi.org\/10.1182\/blood-2012-09-306639","journal-title":"Blood"},{"issue":"1\u20133","key":"1689_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bpc.2010.08.009","volume":"152","author":"MR Falvo","year":"2010","unstructured":"Falvo MR, Gorkun OV, Lord ST (2010) The molecular origins of the mechanical properties of fibrin. Biophys Chem 152(1\u20133):15\u201320. https:\/\/doi.org\/10.1016\/j.bpc.2010.08.009","journal-title":"Biophys Chem"},{"issue":"11","key":"1689_CR33","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/bi0525369","volume":"45","author":"I Pechik","year":"2006","unstructured":"Pechik I, Yakovlev S, Mosesson MW, Gilliland GL, Medved L (2006) Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. Biochemistry 45(11):3588\u20133597. https:\/\/doi.org\/10.1021\/bi0525369","journal-title":"Biochemistry"},{"issue":"1","key":"1689_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2007.02.011","volume":"121","author":"R Kotlin","year":"2007","unstructured":"Kotlin R, Chytilova M, Suttnar J, Riedel T, Salaj P, Blatny J, Santrucek J, Klener P, Dyr JE (2007) Fibrinogen Novy Jicin and Praha II: cases of hereditary Aalpha 16 Arg\u2013>Cys and Aalpha 16 Arg\u2013>His dysfibrinogenemia. Thromb Res 121(1):75\u201384. https:\/\/doi.org\/10.1016\/j.thromres.2007.02.011","journal-title":"Thromb Res"},{"issue":"1","key":"1689_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06630.x","volume":"138","author":"VH Flood","year":"2007","unstructured":"Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH (2007) Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability. Br J Haematol 138(1):117\u2013124. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06630.x","journal-title":"Br J Haematol"},{"issue":"5","key":"1689_CR36","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1160\/TH10-03-0161","volume":"104","author":"S Vorjohann","year":"2010","unstructured":"Vorjohann S, Fish RJ, Biron-Andreani C, Nagaswami C, Weisel JW, Boulot P, Reyftmann L, de Moerloose P, Neerman-Arbez M (2010) Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob \u2018A\u2019. Thromb Haemost 104(5):990\u2013997. https:\/\/doi.org\/10.1160\/TH10-03-0161","journal-title":"Thromb Haemost"},{"issue":"3","key":"1689_CR37","first-page":"619","volume":"27","author":"J Soria","year":"1972","unstructured":"Soria J, Soria C, Samama M, Poirot E, Kling C (1972) Fibrinogen Troyes\u2013fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Thrombosis et diathesis haemorrhagica 27(3):619\u2013633","journal-title":"Thrombosis et diathesis haemorrhagica"},{"issue":"1","key":"1689_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/oxfordjournals.jbchem.a122046","volume":"102","author":"T Miyata","year":"1987","unstructured":"Miyata T, Terukina S, Matsuda M, Kasamatsu A, Takeda Y, Murakami T, Iwanaga S (1987) Fibrinogens Kawaguchi and Osaka: an amino acid substitution of A alpha arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two A alpha chains. J Biochem 102(1):93\u2013101","journal-title":"J Biochem"},{"issue":"6","key":"1689_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0049-3848(95)00086-7","volume":"78","author":"DA Meh","year":"1995","unstructured":"Meh DA, Siebenlist KR, Galanakis DK, Bergtrom G, Mosesson MW (1995) The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16. Thromb Res 78(6):531\u2013539","journal-title":"Thromb Res"},{"issue":"7","key":"1689_CR40","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1046\/j.1538-7836.2003.00278.x","volume":"1","author":"RF Doolittle","year":"2003","unstructured":"Doolittle RF (2003) X-ray crystallographic studies on fibrinogen and fibrin. J Thromb Haemost 1(7):1559\u20131565","journal-title":"J Thromb Haemost"},{"issue":"Suppl1","key":"1689_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1538-7836.2007.02504.x","volume":"5","author":"JW Weisel","year":"2007","unstructured":"Weisel JW (2007) Structure of fibrin: impact on clot stability. J Thromb Haemost 5(Suppl1):116\u2013124. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02504.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1689_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1172\/JCI115841","volume":"90","author":"J Koopman","year":"1992","unstructured":"Koopman J, Haverkate F, Lord ST, Grimbergen J, Mannucci PM (1992) Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. J Clin Investig 90(1):238\u2013244. https:\/\/doi.org\/10.1172\/JCI115841","journal-title":"J Clin Investig"},{"issue":"8","key":"1689_CR43","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1073\/pnas.89.8.3478","volume":"89","author":"J Koopman","year":"1992","unstructured":"Koopman J, Haverkate F, Grimbergen J, Engesser L, Novakova I, Kerst AF, Lord ST (1992) Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes. Proc Natl Acad Sci USA 89(8):3478\u20133482","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1689_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0038-1647646","volume":"60","author":"L Engesser","year":"1988","unstructured":"Engesser L, Koopman J, de Munk G, Haverkate F, Novakova I, Verheijen JH, Briet E, Brommer EJ (1988) Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA. Thromb Haemost 60(1):113\u2013120","journal-title":"Thromb Haemost"},{"issue":"34","key":"1689_CR45","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","volume":"267","author":"DA Gabriel","year":"1992","unstructured":"Gabriel DA, Muga K, Boothroyd EM (1992) The effect of fibrin structure on fibrinolysis. J Biol Chem 267(34):24259\u201324263","journal-title":"J Biol Chem"},{"issue":"5","key":"1689_CR46","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","volume":"20","author":"JP Collet","year":"2000","unstructured":"Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 20(5):1354\u20131361","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1689_CR47","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1182\/blood.V84.11.3709.bloodjournal84113709","volume":"84","author":"Y Wada","year":"1994","unstructured":"Wada Y, Lord ST (1994) A correlation between thrombotic disease and a specific fibrinogen abnormality (A alpha 554 Arg\u2013>Cys) in two unrelated kindred, Dusart and Chapel Hill III. Blood 84(11):3709\u20133714","journal-title":"Blood"},{"issue":"Suppl1","key":"1689_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jth.12229","volume":"11","author":"RA Ariens","year":"2013","unstructured":"Ariens RA (2013) Fibrin(ogen) and thrombotic disease. J Thromb Haemost 11(Suppl1):294\u2013305. https:\/\/doi.org\/10.1111\/jth.12229","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-018-1689-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-018-1689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T01:02:04Z","timestamp":1661389324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-018-1689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1689"],"URL":"https:\/\/doi.org\/10.1007\/s11239-018-1689-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"5 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Review Board of the First Affiliated Hospital of Guangxi Medical University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}